S-glutathionylated PFKFB3 homo-2-mer 3-461
2×ADP; 4×MLA; 2×ACY; 2×GSH; 2×F6P; Assess PFKFB3 in complex with ADP and PEP homo-2-mer 3-461
2×F6P; 2×ADP; 2×PEP; Assess Crystal structure of PFKFB3 in complex with ADP and Fructose-2,6-bisphosphate homo-2-mer 3-461
2×FDP; 2×F6P; 2×ADP; 2×PHS; Assess PFKFB3 trapped in a phospho-enzyme intermediate state homo-2-mer 4-460
2×FDP; 2×PHS; 2×ADP; 2×F6P; Assess Human PFKFB3 in complex with an indole inhibitor 6 homo-2-mer 2-446
2×PHS; 4×PO4; 2×F6P; 2×8V1; Assess Human PFKFB3 in complex with an indole inhibitor 2 homo-2-mer 2-446
2×PHS; 2×PO4; 2×F6P; 2×S6L; Assess human PFKFB3 in complex with a pyrrolopyrimidone compound homo-2-mer 2-446
2×PO4; 2×PHS; 2×F6P; 2×BKI; Assess human PFKFB3 in complex with a pyrrolopyrimidone compound homo-2-mer 2-446
2×PHS; 2×PO4; 2×F6P; 2×BKS; Assess human PFKFB3 in complex with a pyrrolopyrimidone compound homo-2-mer 2-446
2×PHS; 2×PO4; 2×F6P; 2×BKE; Assess PFKFB3 in complex with PPi homo-2-mer 4-447
6×POP; 4×SRT; 4×EDO; Assess human PFKFB3 in complex with a pyrrolopyrimidone compound homo-2-mer 2-445
4×PO4; 2×PHS; 2×F6P; 2×BKV; Assess Human PFKFB3 in complex with an indole inhibitor 5 homo-2-mer 3-446
2×PHS; 2×F6P; 2×PO4; 2×MJP; Assess Human PFKFB3 in complex with an indole inhibitor 4 homo-2-mer 2-445
2×PHS; 2×PO4; 2×F6P; 2×87T; Assess Human PFKFB3 in complex with an indole inhibitor 3 homo-2-mer 2-445
2×PHS; 2×PO4; 2×F6P; 2×FD9; Assess Human PFKFB3 in complex with an indole inhibitor 1 homo-2-mer 3-446
6×PO4; 2×8R2; 2×FDP; Assess A pseudo substrate complex of 6-phosphofructo-2-kinase of PFKFB homo-2-mer 4-446
4×F6P; 2×MG; 2×ACP; Assess HUMAN PFKFB3 IN COMPLEX WITH KAN0438241 homo-2-mer 4-445
2×DMS; 2×F6P; 2×BWW; 2×ADP; Assess PFKFB3 in complex with Aluminum Tetrafluoride homo-2-mer 4-440
2×ALF; 2×ADP; 2×PEP; 2×CL; Assess Crystal structure of the human inducible form 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase monomer 3-517
1×F6P; 1×EDT; 1×ADP; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 2 monomer 2-447
1×GV5; 1×POP; 1×F6P; 1×FLC; 1×DMS; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 5 monomer 4-447
1×H9Z; 1×POP; 1×FLC; 1×F6P; 1×DMS; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 3 monomer 4-447
1×GV8; 1×F6P; 1×PO4; 1×FLC; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 1 monomer 4-447
1×GV2; 1×POP; 1×FLC; 1×F6P; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 7 monomer 4-447
1×PO4; 1×FLC; 1×HAW; 1×F6P; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 6 monomer 4-447
1×HAT; 1×POP; 1×FLC; 1×F6P; 1×BME; 1×PO4; Assess Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4 monomer 4-446
1×HAK; 1×POP; 1×FLC; 1×F6P; 1×DMS; Assess